Travere Therapeutics's activity chart (see below) currently has 49 price targets and 41 ratings on display.
Analysts' price targets on this stock were met 17.82% of the time, taking 115 days on average.
Most recent stock forecast was given by from on 06-Nov-2020. First documented stock forecast 12-Feb-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Mar-2015
$33
$31
6 years 15 days ago
(06-Nov-2020)
3/13 (23.08%)
$11.43 (52.99%)
416
$36
6 years 15 days ago
(05-Nov-2020)
0/1 (0%)
$36 (0.00%)
Buy Since 22-Apr-2019
$30
$19
6 years 2 months 28 days ago
(24-Aug-2020)
2/4 (50%)
$10.98 (57.73%)
217
Buy Since 30-Oct-2018
$38
$44
6 years 3 months 23 days ago
(29-Jul-2020)
0/2 (0%)
$17.8 (88.12%)
Buy Since 23-Aug-2019
$19
$20
6 years 8 months 27 days ago
(25-Feb-2020)
2/2 (100%)
$4.6 (31.94%)
217
What is RTRX (Travere Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on RTRX (Travere Therapeutics)?
Which analyst has the most public recommendations on RTRX (Travere Therapeutics)?
Which analyst is the currently most bullish on RTRX (Travere Therapeutics)?
Which analyst is the currently most reserved on RTRX (Travere Therapeutics)?